FDA Guidance for Industry FDA approval of New Cancer Treatment Uses for Marketed Drug and Biological Products
“If a product has already been shown to be safe and effective in the treatment of patients with a given type of cancer, a single, adequate and well-controlled, multicenter study demonstrating acceptable safety and effectiveness in another biologically similar pattern of responsiveness to chemotherapy may support labeling for that additional form of cancer”